Chemotherapy News and Research

Latest Chemotherapy News and Research

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

8 Aug 2022
Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

8 Aug 2022
Five-year, $2.7 million grant could help determine the best treatment for lung cancer patients

Five-year, $2.7 million grant could help determine the best treatment for lung cancer patients

5 Aug 2022
Skin cancer is a risk no matter the skin tone. But it may be overlooked in people with dark skin.

Skin cancer is a risk no matter the skin tone. But it may be overlooked in people with dark skin.

5 Aug 2022
Researchers identify a component in the intestine that plays key role in repairing damaged tissue

Researchers identify a component in the intestine that plays key role in repairing damaged tissue

4 Aug 2022
Queen’s researchers receive grant from Breast Cancer Now to search for new treatments

Queen’s researchers receive grant from Breast Cancer Now to search for new treatments

3 Aug 2022
Cold exposure could make it harder for cancer cells to grow, mice study shows

Cold exposure could make it harder for cancer cells to grow, mice study shows

3 Aug 2022
IRB Barcelona researchers discover genetic drivers of clonal hematopoiesis

IRB Barcelona researchers discover genetic drivers of clonal hematopoiesis

2 Aug 2022
UCR researcher employs Actor-Network Theory to open black boxes in breast cancer survivorship care

UCR researcher employs Actor-Network Theory to open black boxes in breast cancer survivorship care

1 Aug 2022
Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

29 Jul 2022
Tannins as therapeutic agents against SARS-CoV-2

Tannins as therapeutic agents against SARS-CoV-2

29 Jul 2022
New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

29 Jul 2022
Study: Over half of the online pharmacies selling chemotherapy drugs operate unsafely or illegally

Study: Over half of the online pharmacies selling chemotherapy drugs operate unsafely or illegally

28 Jul 2022
Oncology trial data not available for independent scrutiny, study finds

Oncology trial data not available for independent scrutiny, study finds

28 Jul 2022
Repurposing an antipsychotic drug to treat various types of cancer

Repurposing an antipsychotic drug to treat various types of cancer

28 Jul 2022
Hearing issues often occur among adult cancer survivors, study reports

Hearing issues often occur among adult cancer survivors, study reports

27 Jul 2022
Creating a Microrobot to One Day Tackle Cancer

Creating a Microrobot to One Day Tackle Cancer

27 Jul 2022
Scientists explore COVID-19-associated pulmonary aspergillosis

Scientists explore COVID-19-associated pulmonary aspergillosis

25 Jul 2022
Improving the immune defenses against blood cancer

Improving the immune defenses against blood cancer

22 Jul 2022
Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

22 Jul 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback